Follicular Lymphoma

Showing NaN - NaN of 18

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • La Jolla, California
  • +7 more
Aug 25, 2023

CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
Jan 20, 2023

Non-Hodgkin Lymphoma, Follicular Lymphoma, DLBCL Trial in Australia, Korea, Republic of, United States (IGM-2323)

Recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • Duarte, California
  • +23 more
Dec 28, 2022

Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

Recruiting
  • Mantle Cell Lymphoma
  • +9 more
  • L-Bcl-2 antisense oligonucleotide
  • Augusta, Georgia
  • +2 more
Nov 18, 2022

Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Fort Myers, Saint Petersburg, Nashville (Ublituximab, Umbralisib)

Terminated
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Fort Myers, Florida
  • +2 more
Jul 20, 2022

Follicular Lymphoma, Lymphoma, Follicular Trial in United States (Zevalin Therapeutic Regimen, R-CVP)

Terminated
  • Follicular Lymphoma
  • Lymphoma, Follicular
  • Zevalin Therapeutic Regimen
  • R-CVP
  • Jacksonville, Florida
  • +5 more
Dec 16, 2021

Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

Completed
  • Acute Lymphocytic Leukemia
  • +6 more
  • Haploidentical Bone Marrow Transplant
  • Double Umbilical Cord Blood Transplant
  • Birmingham, Alabama
  • +38 more
Nov 2, 2021

Follicular Lymphoma Trial in Worldwide (ibrutinib, to match ibrutinib, rituximab)

Active, not recruiting
  • Follicular Lymphoma
  • Mobile, Alabama
  • +168 more
Oct 6, 2021

Follicular Lymphoma Trial in Japan, United States (Rituximab, Lenalidomide, Rituximab-CHOP)

Active, not recruiting
  • Follicular Lymphoma
  • Chandler, Arizona
  • +46 more
Jan 8, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

Terminated
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Entospletinib MM
  • Entospletinib SDD
  • Birmingham, Alabama
  • +47 more
Nov 2, 2020

Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Denver, Nashville, Houston (TC-110 T

Recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • TC-110 T Cells
  • +2 more
  • Denver, Colorado
  • +2 more
Jun 25, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

Follicular Lymphoma, DLBCL Trial in Worldwide (Obinutuzumab, Pinatuzumab Vedotin, Polatuzumab Vedotin)

Completed
  • Follicular Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Los Angeles, California
  • +40 more
Feb 20, 2020

Follicular Lymphoma Trial in Worldwide (IXAZOMIB)

Completed
  • Follicular Lymphoma
  • Boston, Massachusetts
  • +13 more
Oct 7, 2019

Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in United States (Idelalisib, Rituximab)

Terminated
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Long Beach, California
  • +5 more
May 1, 2019